Join
IsoPlexis Corporation logo

ISO

NASDAQ

IsoPlexis Corporation

SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusIPO2021
$0.75+0.02 (+2.09%)
News25/Ratings7

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations without the need for highly specialized informatics professionals, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

Latest news

25 items

ISO FAQ

7 questions
  • What does IsoPlexis Corporation do?
    IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples...
  • Where does ISO stock trade?
    IsoPlexis Corporation (ISO) is listed on NASDAQ.
  • What sector and industry is ISO in?
    IsoPlexis Corporation operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.
  • When did IsoPlexis Corporation go public?
    IsoPlexis Corporation (ISO) completed its IPO in 2021.
  • What are analysts saying about ISO?
    IsoPlexis Corporation has had 7 recent analyst actions on file. The most recent action was from Morgan Stanley: Overweight with a $1200.00 price target on 2022-02-15. Recent price targets range from $1200.00 to $2400.00.
  • What companies are similar to ISO?
    Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare ISO side-by-side with any of them on Quantisnow.
  • How can I track ISO on Quantisnow?
    Quantisnow aggregates IsoPlexis Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISO to receive live email and push alerts on every new disclosure.